Pharming Group NV (PHAR)
16.19
-0.18
(-1.10%)
USD |
NASDAQ |
Feb 10, 16:00
16.19
0.00 (0.00%)
After-Hours: 20:00
Pharming Group Total Assets (Quarterly) : 473.78M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| uniQure NV | 888.38M |
| ProQR Therapeutics NV | 146.11M |
| argenx SE | -- |
| Pharvaris NV | 398.20M |
| NewAmsterdam Pharma Co. NV | 786.43M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 209.14M |
| Shareholders Equity (Quarterly) | 264.64M |
| Debt to Equity Ratio | 0.4947 |
| Current Ratio | 3.158 |
| Net Debt Paydown Yield | 0.04% |